Lonnel Coats, Lexicon Pharmaceuticals CEO
Lexicon gears up for another shot in diabetes as path forward agreed with FDA
Lexicon Pharmaceuticals is preparing to resubmit its type 1 diabetes drug candidate to the FDA after its first attempt at approval was met with a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
